MYNZ — Mainz Biomed NV Balance Sheet
0.000.00%
- $7.64m
- $6.96m
- $0.90m
Annual balance sheet for Mainz Biomed NV, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.204 | 0.123 | 8.73 | 17.1 | 7.07 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.041 | 0.044 | 0.112 | 0.259 | 0.355 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.26 | 0.186 | 9.61 | 18.4 | 8.98 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.456 | 0.487 | 0.432 | 1.84 | 3.03 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 0.716 | 0.673 | 10 | 20.2 | 15.4 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.46 | 0.702 | 1.35 | 4.24 | 9.24 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.67 | 3.41 | 3.68 | 6.14 | 12.2 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -1.95 | -2.74 | 6.36 | 14.1 | 3.25 |
Total Liabilities & Shareholders' Equity | 0.716 | 0.673 | 10 | 20.2 | 15.4 |
Total Common Shares Outstanding |